Another study found that ubiquitin-conjugating enzyme E2T (UBE2T) is upregulated in HCC, and HCC patients with higher levels of UBE2T are less sensitive to radiotherapy. This evidence concerns the gene UBE2T and hepatocellular carcinoma.